Kallyope

Discovering novel therapeutics for neurological and metabolic diseases

placeNew York City, New York, United States calendar_todayFounded 2014 groups84 employees language kallyope.com

Registered entities

Innovation

29 patent families (6 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace steady. Cited 2,222 times.

YearFilings
20151
20202
20216
202211
202313
202413
202511
20262

Social engagement

Social engagement: 8.3K social following, 10 posts in the last 12 months — around the industry typical range.

Investor mix

23 investors on record; lead investors include Illumina Ventures, Alexandria, The Column Group, Lux Capital.

Investor typeCountShare
Venture capital939%
Private equity313%
Angel & family office14%
Other / undisclosed1043%

Recent activity

6 Jun 2026
Event
AHS26
28 May 2026
Event
American Headache Society 68th Annual Scientific Meeting
30 Apr 2026
Event
2026 American Academy of Neurology Annual Meeting
Coming soon